Bormioli Pharma works closely with the pharmaceutical industry and all companies committed to leveraging the future of healthcare globally. As a world-renowned packaging player, the company serves both the pharmaceutical and biopharmaceutical market with complete solutions, including glass and plastic bottles, plastic and aluminium closures and accessories. The company’s extensive product ranges are designed and manufactured with a focus on innovation while addressing growing demands for sustainability. Furthermore, each product is specifically designed for the target market through careful portfolio segmentation.

With a global presence in over 100 countries, more than 1,400 employees and 9 plants in Europe specialising in the production of glass and plastic packaging, Bormioli Pharma produces more than 7 billion parts each year. In 2022 alone, the company had an annual turnover of more than EUR 315 million.

In its commitment to delivering lasting benefits for partners through innovation, Bormioli Pharma has launched “Bormioli Pharma Invents”, an open innovation program based on the collaboration between Universities, Start-ups, Research Centers and the internal R&D.

Within Bormioli Pharma’s expansive network of internal and external stakeholders, Innovation Hubs and accelerators are active participants. These entities enable the Group to remain at the forefront of innovation, adopting a crowdsourcing approach to amplify and expedite its developmental endeavors.

As a dedicated ally to the pharmaceutical sector, Bormioli Pharma passionately invests and drives innovation with a singular mission: making health a positive practice, accessible to everyone, kind to the planet.

Uncover the journeys of Bormioli Pharma and fellow industry trailblazers as they embark on a transformative mission to reshape the landscape of healthcare.